ArticleOncoimmunology
Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma
Yaya Chu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
cites it